HemChip®: multi-target diagnostics

Many markers in one run, results in under 30 minutes, wherever they are needed.

< 30 min Multi-target POC

Comparison

HemChip® vs traditional testing

CriteriaTraditional testingHemChip®
Time to resultHours to days< 30 minutes
Equipment costVery high ($50K–$500K)Low (compact reader)
Targets1–2 per runMany at once
StaffingTrained techniciansNon-specialists
LocationCentral laboratoryOn site, in the field
Output dataManual, hard to integrateDigital, AI-ready

Market

Point-of-care & biochip market

Demand for fast, decentralised analysis keeps growing.

POC market 2024
$47.8B
POC market 2030 · 5.8% CAGR
$68.5B
Biochip market 2030 · 10–12% CAGR
$40B+
Multi-target diagnostics market
$20–25B

Where it is used

Analysis anywhere

  • Clinics and community health facilities
  • Continuous health monitoring
  • In the field: epidemiology, veterinary, agriculture
  • Emergencies and emerging outbreaks

HemChip® is a product of Hememics Biotechnologies, Inc. (USA). Medical and diagnostic use in Vietnam will follow the applicable regulations.

The HemChip® reader

Partnering to build the technology of the future

Companies, research institutions and technology partners interested in graphene, biochips or our factory project – get in touch.

Partner with us →